Patients who received oral tranexamic acid 500 mg daily for 3 months had reduced melasma severity and systemic inflammation markers.

HealthDay News — Dozens of people in northeastern England have developed a rare and dangerous illness after receiving Botox injections, according to health officials in the U.K.

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately ...

Early childhood atopic dermatitis does not affect executive function during middle childhood, particularly in those with mild phenotypes.

The intensity of CKD-aP is linked to levels of systemic inflammation, with reductions in these levels seen with difelikefalin treatment.

Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.

Keytruda (pembrolizumab) is approved for head and neck squamous cell carcinoma as a perioperative treatment regimen.

The LGBTQ+ specialized subprogram of the 988 National Suicide and Crisis Lifeline will no longer be available after July 17, 2025.

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Platelet-rich plasma combined with fractional laser therapy was a safe and effective treatment option for adults with vitiligo.

Experienced epidemiologist Dr Fiona Havers resigned from the CDC due to her lack of confidence in the current leadership.